Sanctura FDA Approval History
FDA Approved: Yes (Discontinued) (First approved May 28, 2004)
Brand name: Sanctura
Generic name: trospium chloride
Dosage form: Tablets
Company: Allergan plc
Treatment for: Urinary Frequency, Urinary Incontinence, Overactive Bladder
Marketing Status: Discontinued
Sanctura (trospium chloride) is an antispasmodic, antimuscarinic agent indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
Development timeline for Sanctura
| Date | Article |
|---|---|
| Aug 6, 2007 | Approval Indevus Announces FDA Approval of Sanctura XR |
| May 28, 2004 | Approval Sanctura Indevus Pharmaceuticals, Inc. - Treatment for Overactive Bladder |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
